Epsilon Consulting worked with a major client to develop a scientific narrative for an existing product in order to implement a future growth strategy.
Scientific and clinical data supporting the mechanism of action, disease area knowledge and existing data was used to develop a Phase 4 strategy in support market and sales growth. Therapeutic product strategic direction based on a coherent vision and strong, credible scientific foundation.